Adam Chazan Joins Cowen’s Health Care Investment Banking Team
Cowen Inc. (NASDAQ:COWN) has announced the appointment of Adam Chazan as Managing Director in its Investment Banking division, overseeing the Tools and Diagnostics banking practice. Based in New York, Chazan brings over a decade of experience from Bank of America, enhancing Cowen's influence in health care investment banking. The company's leadership highlighted Chazan's expertise as pivotal in supporting disruptive health care companies and maintaining Cowen's competitive edge in the sector.
- Adam Chazan's appointment strengthens Cowen's health care investment banking practice.
- Chazan has over 10 years of relevant experience, which could enhance service delivery to clients.
- Cowen's established leadership in health care positions the firm favorably for future growth.
- None.
NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Adam Chazan has joined the Company’s Investment Banking division as a Managing Director with leadership responsibility for the firm’s Tools and Diagnostics banking practice. Mr. Chazan will be based in New York and report to George Milstein, Head of the Health Care Investment Banking Group.
“We are excited to have Adam join our team, adding to Cowen’s leading health care investment banking franchise,” said Larry Wieseneck, Co-President, Cowen and Company. “Over the last several years, Cowen has solidified its position as a leader across the health care landscape where novel tools, technologies and health care converge. Adam’s deep expertise, network and leadership skills make him the perfect partner to help us accelerate our leading position in the future of health care solutions.”
“Cowen’s position supporting and partnering with the entrepreneurs and companies changing the face of health care is well established. I look forward to working with the Cowen team to provide world class advice and execution to a fast-growing list of disruptive companies,” said Mr. Chazan.
Mr. Milstein noted, “I have known Adam as both a friend and a colleague for many years. It is the perfect time for him to be joining Cowen given the significant momentum in our future health practice. With Adam’s leadership we are well positioned to support clients through the continued evolution of Health Care.”
Prior to joining Cowen, he spent 10 years at Bank of America, most recently as the Global Co-Head of Medical Technology Investment Banking. Before that, Mr. Chazan held positions at Leerink Swan, Merril Lynch, Pacific Growth Equities, ING and William Blair. Mr. Chazan received a B.S. in Biology and Biological Sciences from Cornell University and an M.S. in Biotechnology from Northwestern University.
About Cowen Inc.
Cowen Inc. (“Cowen” or the “Company”) is a diversified financial services firm that operates through two business segments: a broker dealer and an investment management division. The Company’s broker dealer division offers investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing and commission management services. Cowen’s investment management segment offers actively managed alternative investment products. Cowen Inc. focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the firm is headquartered in New York and has offices worldwide. Learn more at Cowen.com.
© 2021, COWEN INC., ALL RIGHTS RESERVED. COWEN AND COMPANY, LLC: MEMBER FINRA, NYSE AND SIPC
Media Contact:
Gagnier Communications
Dan Gagnier
646-569-5897
dg@gagnierfc.com
FAQ
Who is Adam Chazan at Cowen Inc.?
What role will Chazan play in Cowen's Investment Banking division?
What experience does Adam Chazan bring to Cowen?
What impact will Chazan's appointment have on Cowen's health care sector?
When was Adam Chazan appointed to Cowen Inc.?
